Introduction: Pediatric multiple sclerosis (MS) is a chronic autoimmune demyelinating disorder of the central nervous system that presents unique challenges in diagnosis and management due to its early onset and potential impact on neurological development (1). While fingolimod is currently approved for treating pediatric MS and has demonstrated ef
451 Reached
Woman presented with Fever of Unknown Origin
7733 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35339 Reached151 Comments202 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes
Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes